4.2 Article

Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers

期刊

PHARMACOGENOMICS
卷 13, 期 10, 页码 1129-1139

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/PGS.12.93

关键词

CHL1; genome-wide expression profiling; let-7b; let-7c; miR-132; miR-151-3p; miR-212; miR-30b*; selective serotonin reuptake inhibitors

资金

  1. Chief Scientist office, Ministry of Health, Israel of ERA-Net Neuron
  2. NIH [R01DC011835]
  3. Chief Scientist Office, Ministry of Health, Israel
  4. Israel Cancer Association, Israel
  5. Wolfson Family Charitable Fund
  6. Planning and Budgeting Committee, Israel
  7. Israel Science Foundation, Israel [41/11]

向作者/读者索取更多资源

Aim: Over 30% of patients with major depression do not respond well to first-line treatment with selective serotonin reuptake inhibitors (SSRIs). Using genome-wide expression profiling of human lymphoblastoid cell lines (LCLs) CHL1 was identified as a tentative SSRI sensitivity biomarker. This study reports on miRNAs implicated in SSRI sensitivity of LCLs. Methods: Eighty LCLs were screened from healthy adult female individuals for growth inhibition by paroxetine. Eight LCLs exhibiting high or low sensitivities to paroxetine were chosen for genome-wide expression profiling with miRNA microarrays. Results: The miRNA miR-151-3p had 6.7-fold higher basal expression in paroxetine-sensitive LCLs. This corresponds with lower expression of CHL1, a target of miR-151-3p. The additional miRNAs miR-212, miR-132, miR-30b*, let-7b and let-7c also differed by >1.5-fold (p < 0.05) between the two LCL groups. Conclusion: The potential value of these miRNAs as tentative SSRI response biomarkers awaits validation with lymphocyte samples of major depression patients. Original submitted 28 March 2012; Revision submitted 21 May 2012

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Role of cytochrome P450 2C8 genetic polymorphism and epoxygenase uncoupling in periodontal remodelling affecting orthodontic treatment

Sabrina Yamoune, Katharina Wintz, Christian Niederau, Rogerio B. Craveiro, Michael Wolf, Julia Stingl

Summary: The study found that genetic polymorphism in the CYP2C8 gene may be associated with disturbed periodontal remodeling in periodontal fibroblasts, potentially contributing to the risk of side effects of antiresorptive bone treatment.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)

Article Pharmacology & Pharmacy

Validation of self-reported medication use applying untargeted mass spectrometry-based metabolomics techniques in the Rhineland study

Nersi Alaeddin, Julia C. Stingl, Monique M. B. Breteler, Folgerdiena M. de Vries

Summary: The study aimed to evaluate the reliability of self-reported medication use by comparing it with drug-specific metabolites measured in plasma in a population-based cohort in Germany. The results showed high concordance rates between self-reported drug use and metabolites, suggesting that self-reported drug use is reliable and accurate for assessing drug use.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Geriatrics & Gerontology

The relationship of weather with daily physical activity and the time spent out of home in older adults from Germany - the ActiFE study

Matthias Klimek, Raphael Simon Peter, Michael Denkinger, Dhayana Dallmeier, Kilian Rapp, Dietrich Rothenbacher, Jochen Klenk

Summary: This study investigated the associations between weather conditions and walking duration and time spent out-of-home (TOH) among older adults. The results showed that higher temperatures, solar radiation, and sunshine duration led to increased walking duration and TOH, while higher precipitation, humidities, and windspeeds led to a decrease. Women generally had longer walking duration and TOH times than men.

EUROPEAN REVIEW OF AGING AND PHYSICAL ACTIVITY (2022)

Article Oncology

Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer

Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, Kathrin Mollenhoff, Klaus Baumann, Christian Jackisch, Jan Hauke, Dimo Dietrich, Julika Borde, Tjoung-Won Park-Simon, Lars Hanker, Katharina Prieske, Sandra Schmidt, Nana Weber-Lassalle, Esther Pohl-Rescigno, Stefan Kommoss, Frederik Marme, Florian Heitz, Julia C. Stingl, Rita K. Schmutzler, Philipp Harter, Eric Hahnen

Summary: Cancer patients, particularly those with ovarian cancer, have a high prevalence of blood-specific mutations in clonal hematopoiesis (CH)-associated genes, which may be influenced by genetic factors.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

Article Biotechnology & Applied Microbiology

Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry

Bianza T. Mbavha, Comfort R. Kanji, Nadina Stadler, Julia Stingl, Andrea Stanglmair, Catharina Scholl, William Wekwete, Collen Masimirembwa

Summary: This study sequenced clinically actionable genetic variants in a Zimbabwean population using a custom-designed array, and identified metabolism-related genes for commonly used drugs in Zimbabwe. The results showed significant genetic variations in the Zimbabwean population, which are important for the safe and efficacious use of drugs. The established cohort of genotyped volunteers can be used for future pharmacogenetic studies on drugs for people of African ancestry.

PHARMACOGENETICS AND GENOMICS (2022)

Article Genetics & Heredity

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

Jochen Fracowiak, Tatjana Huebner, Steffen Hess, Christoph Roethlein, Daria Langner, Udo Schneider, Felix Falkenberg, Catharina Scholl, Roland Linder, Julia Stingl, Britta Haenisch, Michael Steffens

Summary: This study, EMPAR, elucidates the impact of genetic variability of pharmacogenes as a possible risk factor for adverse drug reactions. The study evaluates the possible associations of pharmacogenetically predicted metabolic profiles relevant for the metabolism of frequently prescribed cardiovascular drugs and performs analyses and evaluations on a German study population.

PHARMACOGENOMICS JOURNAL (2022)

Review Pharmacology & Pharmacy

Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta-analysis

Seenae Eum, Franklin Sayre, Adam M. Lee, Julia C. Stingl, Jeffrey R. Bishop

Summary: This study aimed to quantify the association of CYP2B6 variant alleles and genotype-defined metabolizer phenotypes with bupropion and HB exposure. The results showed that the CYP2B6*6 allele and genotype-defined CYP2B6 poor and intermediate metabolizer phenotypes are associated with significantly lower exposures to HB and the total active moiety.

PHARMACOTHERAPY (2022)

Article Virology

Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera

Marie-Luise Herrlein, Sascha Hein, Tobias Zahn, Ines Mhedhbi, Jan Raupach, Younes Husria, Nuka Ivalu Benz, Jonathan Eisert, Daniela Bender, Vanessa Haberger, Florian D. Hastert, Lisa Henss, Barbara S. Schnierle, Julia C. Stingl, Michael Dreher, Eberhard Hildt

Summary: With the increasing number of vaccinated and convalescent individuals, there is a need for robust methods to quantify neutralizing antibodies. This study compared different neutralization assays using sera from hospitalized COVID-19 patients and found comparable data. The results provide insights into the neutralizing potential of SARS-CoV-2-specific sera.

VIRUSES-BASEL (2022)

Article Pharmacology & Pharmacy

Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations

Ingmar Bergs, Katja S. Just, Catharina Scholl, Michael Dreher, Julia C. Stingl

Summary: This study aimed to analyze the association between inhaled therapy and adverse drug reactions (ADRs) in COPD patients, with a focus on the impact of overdose. The results showed that overdose of inhaled therapies led to severe ADRs and affected emergency room presentations. These ADRs are rarely associated with inhaled therapy by healthcare professionals or patients. Due to the high volume of prescriptions for inhaled drugs, greater attention should be paid to pharmacovigilance and patient education in COPD patients.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Biochemistry & Molecular Biology

Machine Learning-Based Blood RNA Signature for Diagnosis of Autism Spectrum Disorder

Irena Voinsky, Oleg Y. Fridland, Adi Aran, Richard E. Frye, David Gurwitz

Summary: Early diagnosis of ASD is crucial, but the current process is lengthy due to the lack of reliable biomarkers. In this study, we used RNA-sequencing to identify dysregulated genes in ASD children and developed machine learning models for ASD diagnosis. Our models achieved an accuracy of 82% in distinguishing ASD children from NT children, but further validation is needed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Psychiatry

Meta-analysis of brain samples of individuals with schizophrenia detects down-regulation of multiple ATP synthase encoding genes in both females and males

Noa Katz Shroitman, Assif Yitzhaky, Dorit Ben Shachar, David Gurwitz, Libi Hertzberg

Summary: Schizophrenia is a chronic and debilitating mental disorder with unknown causes. This study investigated the expression of ATP synthase encoding genes in postmortem brain samples of individuals with schizophrenia. The results showed down-regulation of ATP synthase genes in schizophrenia, supporting the hypothesis that reduced ATP synthesis is associated with this disorder. The findings highlight the importance of abnormal cellular energy metabolism in schizophrenia.

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

Article Pediatrics

Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports

Sarah Leitzen, Diana Dubrall, Irmgard Toni, Julia Stingl, Patrick Christ, Ursula Koberle, Matthias Schmid, Antje Neubert, Bernhardt Sachs

Summary: The study compares the differences between ADRs reported in the KiDSafe project and the spontaneous ADR reports sent to EudraVigilance. The results show underreporting of ADRs in the spontaneous reports compared to the systematically collected KiDSafe reports. The two approaches yield different results in terms of reported drugs, ADRs, and medication errors.

PEDIATRIC DRUGS (2023)

Article Chemistry, Medicinal

High purity and integrity RNA from human cell lines stored in liquid nitrogen for over 20 years

Irena Voinsky, Elad Shapira, David Gurwitz

Summary: Biobanks play a crucial role in biomedical research by providing human cell lines for drug development projects. RNA-sequencing of large panels of cell lines from individuals with certain disorders and healthy controls, or with different drug response phenotypes, is commonly performed. In this study, we demonstrate that extracting RNAs directly from long-term frozen human cell lines yields high-quality RNA samples suitable for optimal RNA-sequencing, comparable to those obtained from growing cell lines.

DRUG DEVELOPMENT RESEARCH (2023)

Editorial Material Chemistry, Medicinal

Artificial intelligence utility for drug development: ChatGPT and beyond

David Gurwitz, Noam Shomron

DRUG DEVELOPMENT RESEARCH (2023)

Article Biochemistry & Molecular Biology

Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients

Liron Mizrahi, Ashwani Choudhary, Polina Ofer, Gabriela Goldberg, Elena Milanesi, John R. Kelsoe, David Gurwitz, Martin Alda, Fred H. Gage, Shani Stern

Summary: Bipolar disorder is a mood disorder characterized by recurrent episodes of mania and depression. Many patients do not respond to the first-line treatment drug lithium, making clinical management challenging. By analyzing gene expression in lymphoblastoid cell lines, we identified potential biomarkers for diagnosing and treating bipolar disorder. We also developed machine learning algorithms that accurately predicted lithium response in different patient cohorts. This methodology shows promise for guiding therapeutic interventions.

MOLECULAR PSYCHIATRY (2023)

暂无数据